UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the quarterly period ended
Commission File Number
STANDEX INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
|
| |
| (State of incorporation) | (IRS Employer Identification No.) |
| | |
| (Address of principal executive offices) | (Zip Code) |
| ( (Registrant’s telephone number, including area code) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| | | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| |
| Accelerated filer ☐ |
| |
| Non-accelerated filer ☐ | Smaller reporting company |
| ||
| Emerging growth company |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of shares of Registrant's Common Stock outstanding on April 30, 2025 was
STANDEX INTERNATIONAL CORPORATION
INDEX
|
|
|
Page No. |
| PART I. FINANCIAL INFORMATION: |
|
|
|
|
|
|
| Item 1. |
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2025 and June 30, 2024 (unaudited) |
|
|
|
|
|
|
|
Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2025 and 2024 (unaudited) |
|
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended March 31, 2025 and 2024 (unaudited) |
|
|
|
|
|
|
|
Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 31, 2025 and 2024 (unaudited) |
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2025 and 2024 (unaudited) |
|
|
|
|
|
|
|
Notes to Unaudited Condensed Consolidated Financial Statements |
|
|
|
|
|
| Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
|
|
|
|
| Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
|
|
|
|
|
| Item 4. |
Controls and Procedures |
|
|
|
|
|
| PART II. OTHER INFORMATION: |
|
|
|
|
|
|
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
|
| Item 5. |
Other Information |
43 |
| Item 6. |
Exhibits |
|
PART I. FINANCIAL INFORMATION
ITEM 1
STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Balance Sheets
| March 31, | June 30, | |||||||
| (In thousands, except share and per share data) | 2025 | 2024 | ||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Accounts receivable, less allowance for credit losses of $ and $ at March 31, 2025 and June 30, 2024, respectively | ||||||||
| Inventories | ||||||||
| Contract assets | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Property, plant, and equipment, net | ||||||||
| Intangible assets, net | ||||||||
| Goodwill | ||||||||
| Deferred tax asset | ||||||||
| Operating lease right-of-use asset | ||||||||
| Other non-current assets | ||||||||
| Total non-current assets | ||||||||
| Total assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued liabilities | ||||||||
| Income taxes payable | ||||||||
| Total current liabilities | ||||||||
| Long-term debt | ||||||||
| Operating lease long-term liabilities | ||||||||
| Accrued pension and other non-current liabilities | ||||||||
| Total non-current liabilities | ||||||||
| Contingencies (Note 15) | ||||||||
| Redeemable noncontrolling interest | ||||||||
| Stockholders' equity: | ||||||||
| Common stock, par value $ per share, shares authorized, shares issued, and shares outstanding at March 31, 2025 and June 30, 2024 | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
| Treasury shares: and shares at March 31, 2025 and June 30, 2024 | ( | ) | ( | ) | ||||
| Total stockholders' equity | ||||||||
| Total liabilities and stockholders' equity | $ | $ | ||||||
See notes to unaudited condensed consolidated financial statements
STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Operations
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| (In thousands, except per share data) |
2025 |
2024 |
2025 |
2024 |
||||||||||||
| Net sales |
$ | $ | $ | $ | ||||||||||||
| Cost of sales |
||||||||||||||||
| Gross profit |
||||||||||||||||
| Selling, general, and administrative expenses |
||||||||||||||||
| (Gain) loss on sale of business |
( |
) | ||||||||||||||
| Restructuring costs |
||||||||||||||||
| Acquisition related costs |
||||||||||||||||
| Other operating expense, net |
||||||||||||||||
| Total operating expenses |
||||||||||||||||
| Income from operations |
||||||||||||||||
| Interest expense |
||||||||||||||||
| Other non-operating expense, net |
||||||||||||||||
| Income from continuing operations before income taxes |
||||||||||||||||
| Provision (benefit) for income taxes |
( |
) | ||||||||||||||
| Income from continuing operations |
||||||||||||||||
| (Loss) from discontinued operations, net of tax |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Net income |
||||||||||||||||
| Less: net income attributable to redeemable noncontrolling interest |
||||||||||||||||
| Net income attributable to Standex International Corporation |
$ | $ | $ | $ | ||||||||||||
| Basic earnings (loss) per share attributable to Standex International Corporation shareholders: |
||||||||||||||||
| Continuing operations |
$ | $ | $ | $ | ||||||||||||
| Discontinued operations |
( |
) | ( |
) | ||||||||||||
| Total |
$ | $ | $ | $ | ||||||||||||
| Diluted earnings (loss) per share attributable to Standex International Corporation shareholders: |
||||||||||||||||
| Continuing operations |
$ | $ | $ | $ | ||||||||||||
| Discontinued operations |
( |
) | ( |
) | ||||||||||||
| Total |
$ | $ | $ | $ | ||||||||||||
| Weighted average number of shares: |
||||||||||||||||
| Basic |
||||||||||||||||
| Diluted |
||||||||||||||||
See notes to unaudited condensed consolidated financial statements
STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| (In thousands) |
2025 |
2024 |
2025 |
2024 |
||||||||||||
| Net income |
$ | $ | $ | $ | ||||||||||||
| Other comprehensive income (loss): |
||||||||||||||||
| Defined benefit pension plans: |
||||||||||||||||
| Actuarial gains (losses) and other changes in unrecognized costs, net of tax |
$ | ( |
) | $ | $ | ( |
) | $ | ||||||||
| Amortization of unrecognized costs, net of tax |
||||||||||||||||
| Derivative instruments: |
||||||||||||||||
| Change in unrealized gains (losses), net of tax |
( |
) | ||||||||||||||
| Amortization of unrealized gains (losses) into interest expense, net of tax |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Foreign currency translation gains (losses), net of tax |
( |
) | ( |
) | ||||||||||||
| Other comprehensive income (loss) |
( |
) | ( |
) | ||||||||||||
| Total comprehensive income (loss) |
||||||||||||||||
| Less: comprehensive income (loss) attributable to redeemable noncontrolling interest |
||||||||||||||||
| Total comprehensive income (loss) attributable to Standex International Corporation |
$ | $ | $ | $ | ||||||||||||
See notes to unaudited condensed consolidated financial statements
STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Stockholders' Equity
| Accumulated Other | ||||||||||||||||||||||||||||||||
| For the three month period ended | Redeemable | Additional | Comprehensive | Total | ||||||||||||||||||||||||||||
| March 31, 2025 | Noncontrolling | Common | Paid-in | Retained | Income | Treasury Stock | Stockholders' | |||||||||||||||||||||||||
| (in thousands, except as specified) | Interest | Stock | Capital | Earnings | (Loss) | Shares | Amount | Equity | ||||||||||||||||||||||||
| Balance, December 31, 2024 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
| Stock issued under incentive compensation plans and employee purchase plans | - | ( | ) | |||||||||||||||||||||||||||||
| Stock issued for business acquisition | - | |||||||||||||||||||||||||||||||
| Fair value of noncontrolling interest at acquisition | - | - | ||||||||||||||||||||||||||||||
| Stock-based compensation | - | - | ||||||||||||||||||||||||||||||
| Treasury stock acquired | ||||||||||||||||||||||||||||||||
| Comprehensive income: | ||||||||||||||||||||||||||||||||
| Net income | - | - | ||||||||||||||||||||||||||||||
| Foreign currency translation adjustment | - | |||||||||||||||||||||||||||||||
| Pension, net of tax of $ million | ||||||||||||||||||||||||||||||||
| Change in fair value of derivatives, net of tax of $ million | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Dividends declared ($ per share) | ( | ) | - | - | ( | ) | ||||||||||||||||||||||||||
| Balance, March 31, 2025 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
| Accumulated Other | ||||||||||||||||||||||||||||||||
| For the three month period ended March 31, 2024 | Redeemable | Additional | Comprehensive | Total | ||||||||||||||||||||||||||||
| Noncontrolling | Common | Paid-in | Retained | Income | Treasury Stock | Stockholders' | ||||||||||||||||||||||||||
| (in thousands, except as specified) | Interest | Stock | Capital | Earnings | (Loss) | Shares | Amount | Equity | ||||||||||||||||||||||||
| Balance, December 31, 2023 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
| Stock issued under incentive compensation plans and employee purchase plans | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Stock-based compensation | - | - | ||||||||||||||||||||||||||||||
| Treasury stock acquired | - | ( | ) | ( | ) | |||||||||||||||||||||||||||
| Comprehensive income: | ||||||||||||||||||||||||||||||||
| Net income | - | - | ||||||||||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Pension, net of tax of $ million | - | |||||||||||||||||||||||||||||||
| Change in fair value of derivatives, net of tax of $ million | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Dividends declared ($ per share) | ( | ) | - | - | ( | ) | ||||||||||||||||||||||||||
| Balance, March 31, 2024 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
See notes to unaudited condensed consolidated financial statements
STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Stockholders' Equity
| Accumulated Other | ||||||||||||||||||||||||||||||||
| For the nine month period ended | Redeemable | Additional | Comprehensive | Total | ||||||||||||||||||||||||||||
| March 31, 2025 | Noncontrolling | Common | Paid-in | Retained | Income | Treasury Stock | Stockholders' | |||||||||||||||||||||||||
| (in thousands, except as specified) | Interest | Stock | Capital | Earnings | (Loss) | Shares | Amount | Equity | ||||||||||||||||||||||||
| Balance, June 30, 2024 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
| Stock issued under incentive compensation plans and employee purchase plans | ( | ) | ( | ) | ||||||||||||||||||||||||||||
| Stock issued for business acquisition | - | ( | ) | |||||||||||||||||||||||||||||
| Fair value of noncontrolling interest at acquisition | - | |||||||||||||||||||||||||||||||
| Stock-based compensation | - | |||||||||||||||||||||||||||||||
| Treasury stock acquired | ( | ) | ( | ) | ||||||||||||||||||||||||||||
| Comprehensive income: | ||||||||||||||||||||||||||||||||
| Net Income | - | - | ||||||||||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ) | - | |||||||||||||||||||||||||||||
| Pension, net of tax of $ million | ||||||||||||||||||||||||||||||||
| Change in fair value of derivatives, net of tax of $ million | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Dividends declared ($ per share) | ( | ) | - | - | ( | ) | ||||||||||||||||||||||||||
| Balance, March 31, 2025 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
| Accumulated Other | ||||||||||||||||||||||||||||||||
| For the nine month period ended March 31, 2024 | Redeemable | Additional | Comprehensive | Total | ||||||||||||||||||||||||||||
| Noncontrolling | Common | Paid-in | Retained | Income | Treasury Stock | Stockholders' | ||||||||||||||||||||||||||
| (in thousands, except as specified) | Interest | Stock | Capital | Earnings | (Loss) | Shares | Amount | Equity | ||||||||||||||||||||||||
| Balance, June 30, 2023 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
| Stock issued under incentive compensation plans and employee purchase plans | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Stock-based compensation | - | - | ||||||||||||||||||||||||||||||
| Treasury stock acquired | - | ( | ) | ( | ) | |||||||||||||||||||||||||||
| Comprehensive income: | ||||||||||||||||||||||||||||||||
| Net income | - | - | ||||||||||||||||||||||||||||||
| Foreign currency translation adjustment | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Pension, net of tax of $ million | - | |||||||||||||||||||||||||||||||
| Change in fair value of derivatives, net of tax of $ million | ( | ) | - | ( | ) | |||||||||||||||||||||||||||
| Dividends declared ($ per share) | ( | ) | - | - | ( | ) | ||||||||||||||||||||||||||
| Balance, March 31, 2024 | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||||||||||||
See notes to unaudited condensed consolidated financial statements
STANDEX INTERNATIONAL CORPORATION AND SUBSIDIARIES
Unaudited Condensed Consolidated Statements of Cash Flows
| Nine Months Ended |
||||||||
| March 31, |
||||||||
| (In thousands) |
2025 |
2024 |
||||||
| Cash flows from operating activities |
||||||||
| Net income |
$ | $ | ||||||
| Income (loss) from discontinued operations |
( |
) | ( |
) | ||||
| Income from continuing operations |
||||||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
||||||||
| Depreciation and amortization |
||||||||
| Stock-based compensation |
||||||||
| Non-cash portion of restructuring charge |
( |
) | ||||||
| (Gain) loss on sale of business |
( |
) | ||||||
| Contributions to defined benefit plans |
( |
) | ( |
) | ||||
| Changes in operating assets and liabilities, net |
( |
) | ( |
) | ||||
| Net cash provided by (used in) operating activities - continuing operations |
||||||||
| Net cash provided by (used in) operating activities - discontinued operations |
( |
) | ( |
) | ||||
| Net cash provided by (used in) operating activities |
||||||||
| Cash flows from investing activities |
||||||||
| Expenditures for property, plant, and equipment |
( |
) | ( |
) | ||||
| Proceeds from sale of business |
||||||||
| Expenditures for acquisitions, net of cash acquired |
( |
) | ( |
) | ||||
| Other investing activity |
( |
) | ||||||
| Net cash provided by (used in) investing activities |
( |
) | ( |
) | ||||
| Cash flows from financing activities |
||||||||
| Proceeds from borrowings |
||||||||
| Payments of debt |
( |
) | ( |
) | ||||
| Activity under share-based payment plans |
||||||||
| Purchases of treasury stock and other |
( |
) | ( |
) | ||||
| Cash dividends paid |
( |
) | ( |
) | ||||
| Net cash provided by (used in) financing activities |
( |
) | ||||||
| Effect of exchange rate changes on cash and cash equivalents |
( |
) | ||||||
| Net change in cash and cash equivalents |
( |
) | ( |
) | ||||
| Cash and cash equivalents at beginning of year |
||||||||
| Cash and cash equivalents at end of period |
$ | $ | ||||||
| Supplemental Disclosure of Cash Flow Information: |
||||||||
| Cash paid during the year for: |
||||||||
| Interest |
$ | $ | ||||||
| Income taxes, net of refunds |
$ | $ | ||||||
| Stock issued for business acquisition |
$ | $ | ||||||
See notes to unaudited condensed consolidated financial statements
STANDEX INTERNATIONAL CORPORATION
Notes to Unaudited Condensed Consolidated Financial Statements
1) Management Statement
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the results of operations for the three and nine months ended March 31, 2025 and 2024, the cash flows for the nine months ended March 31, 2025 and 2024 and the financial position of Standex International Corporation (“Standex”, the “Company”, “we”, “us”, or “our”), at March 31, 2025. The interim results are not necessarily indicative of results for a full year. The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The unaudited condensed consolidated financial statements and notes do not contain information which would substantially duplicate the disclosures contained in the audited annual consolidated financial statements and notes for the year ended June 30, 2024. The condensed consolidated balance sheet at June 30, 2024 was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements contained herein should be read in conjunction with the Annual Report on Form 10-K and in particular the audited consolidated financial statements for the year ended June 30, 2024. Unless otherwise noted, references to years are to the Company’s fiscal years. Currently the fiscal year end is June 30. For further clarity, the Company's fiscal year 2025 includes the twelve-month period from July 1, 2024 to June 30, 2025.
The preparation of consolidated financial statements in conformity with GAAP requires the use of estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the financial statements and for the period then ended. Estimates are based on historical experience, actuarial estimates, current conditions and various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when they are not readily apparent from other sources. These estimates assist in the identification and assessment of the accounting treatment necessary with respect to commitments and contingencies. Actual results may differ from these estimates under different assumptions or conditions. The estimates and assumptions used in the preparation of the consolidated financial statements have considered the implications on the Company as a result of ongoing global events and related economic impacts. As a result, there is heightened volatility and uncertainty around tariff actions, supply chain performance, labor availability, and customer demand. However, the magnitude of such impact on the Company’s business and its duration is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of March 31, 2025 and the issuance date of the quarterly report on Form 10-Q.
The Company considers events or transactions that occur after the balance sheet date but before the financial statements are issued to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. The Company evaluated subsequent events through the date and time its unaudited condensed consolidated financial statements were issued.
Research and development expenditures are expensed as incurred. Total research and development costs, which are classified under selling, general, and administrative expenses were $
Recently Issued Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed below, the Company does not believe that the adoption of recently issued standards had or may have a material impact on its unaudited condensed consolidated financial statements or disclosures.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) ("ASU 2023-07"). This update provides, among other things, enhanced segment disclosure requirements including disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will review the extent of new disclosures necessary in the coming quarters, prior to implementation during fiscal year 2025. Other than additional disclosure, the Company does not expect a change to its condensed consolidated financial statements upon adoption.
2) Acquisitions
The Company completed acquisition in the third quarter of fiscal 2025 and in the second quarter of fiscal year 2025. At the time of the acquisitions and as of March 31, 2025, the Company evaluated the significance of each acquisition on a standalone basis and in aggregate, considering both qualitative and quantitative factors.
McStarlite
On February 5, 2025, the Company acquired
The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to McStarlite's technical and applications expertise, which is highly complementary to the Company's existing business.
Identifiable intangible assets of $
| Preliminary Allocation as of March 31, 2025 | ||||
| Total purchase consideration: | ||||
| Cash payments | $ | |||
| Less: cash acquired | ( | ) | ||
| Total | $ | |||
| Identifiable assets acquired and liabilities assumed: | ||||
| Other acquired assets | $ | |||
| Inventories | ||||
| Customer backlog | ||||
| Property, plant, and equipment | ||||
| Identifiable intangible assets | ||||
| Goodwill | ||||
| Liabilities assumed | ( | ) | ||
| Total | $ | |||
Amran/Narayan Group
On October 28, 2024 (“Closing Date”), the Company acquired, in separate transactions,
Total consideration for Amran aggregated $
Additionally, on October 28, 2024, as contemplated by the Narayan Purchase Agreement, the Company, Mold-Tech Singapore and the owners of the remaining ownership interest in Narayan, which was not acquired by the Company, entered into a Shareholders’ Agreement. The Shareholders’ Agreement provides the noncontrolling interest holders with certain put rights upon the expiration of the Share Swap Provision. The noncontrolling interest holders will have the right (but not an obligation) to transfer up to their remaining interest in Narayan for a period of years ("Put Option Period") to Mold-Tech Singapore. Subsequent to the expiration of the Put Option Period, Mold-Tech Singapore will have the right (but not an obligation) to acquire the remaining interest in Narayan for an additional year consecutive period.
The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed and noncontrolling interest based on a valuation of their fair values on the Closing Date. Goodwill recorded from this transaction is attributable to Amran/Narayan Group’s technical and applications expertise, which is highly complementary to the Company's existing business.
Identifiable intangible assets of $
The following table summarizes the allocation of the aggregate total consideration for the Amran/Narayan Group to the estimated fair values of the tangible and identifiable intangible assets acquired and liabilities and noncontrolling interest assumed (in thousands):
| Preliminary Allocation as of December 31, 2024 | Adjustments | Preliminary Allocation as of March 31, 2025 | ||||||||||
| Fair value of business combination: | ||||||||||||
| Total cash consideration | $ | $ | $ | |||||||||
| Less: cash acquired | ( | ) | ( | ) | ||||||||
| Stock consideration | - | |||||||||||
| Total | $ | $ | $ | |||||||||
| Identifiable assets acquired and liabilities assumed: | ||||||||||||
| Other acquired assets | $ | $ | $ | |||||||||
| Accounts receivable | ( | ) | ||||||||||
| Inventories | ( | ) | ||||||||||
| Customer backlog | ||||||||||||
| Property, plant, and equipment | ||||||||||||
| Identifiable intangible assets | ||||||||||||
| Goodwill | ||||||||||||
| Deferred tax liabilities, net | ( | ) | ( | ) | ( | ) | ||||||
| Other liabilities assumed | ( | ) | ( | ) | ||||||||
| Total identifiable assets acquired and liabilities assumed | ||||||||||||
| Redeemable noncontrolling interest (see Note 18) | ( | ) | - | ( | ) | |||||||
| Total identifiable assets, liabilities and redeemable noncontrolling interest | $ | $ | $ | |||||||||
The initial allocation of the purchase price is based upon a preliminary valuation, and accordingly, our estimates and assumptions are subject to change as we obtain additional information during the measurement period. The Company anticipates finalizing the purchase price allocation within 12 months from the acquisition date.
The following table reflects the unaudited pro forma operating results of the Company for the three and nine months ended March 31, 2025 and 2024, respectively, which give effect to the acquisition of the Amran/Narayan Group as if it had occurred effective July 1, 2023. The pro forma results are not necessarily indicative of the operating results that would have occurred had the acquisition been effective as of the date indicated, nor are they intended to be indicative of results that may occur in the future. The pro forma information does not include the effects of any synergies related to the Amran/Narayan Group acquisition, transactions between the entities prior to acquisition, or the pre-acquisition impact of other businesses acquired by the Company during this period as they were not material to the Company’s historical results of operations. Pro forma earnings during the periods presented were adjusted to include the following adjustments:
| ● | Amortization of inventory step-up to fair value assuming inventory turns within a two-month period; |
| ● | Amortization of definite-lived intangible assets recognized at fair value that exceed one year as if acquired July 1, 2023; |
| ● | Non-recurring acquisition-related costs have been excluded from net income; |
| ● | Interest expense (including amortization of loan discount) on the Term Loan Credit Agreement entered into in connection with the acquisition as if the loan was obtained July 1, 2023. The interest rate assumed for purposes of the pro forma financial information was |
| ● | Income tax expense (benefit) was adjusted related to the above pro forma adjustments using an estimated tax rate of |
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| (in thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net sales | $ | $ | $ | $ | ||||||||||||
| Net income | ||||||||||||||||
The Company incurred acquisition-related costs of $
From the date of acquisition, the Amran/Narayan Group has contributed $
Nascent Technology
On November 18, 2024, the Company purchased all of the issued and outstanding equity interests of Nascent Technology Manufacturing, LLC ("Nascent") for $
Custom Biogenic Systems
On November 13, 2024, the Company purchased all of the issued and outstanding equity interests of Custom Biogenic Systems for $
Sanyu
On February 19, 2024, the Company completed the purchase of all the issued and outstanding equity interests of Sanyu Switch Co., Ltd ("Sanyu"), a privately held company for $
The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to Sanyu's technical and applications expertise, which is highly complementary to the Company's existing business.
Identifiable intangible assets of $
The components of the fair value of the Sanyu acquisition, including the final allocation of the purchase price are as follows (in thousands):
| Final Allocation as of March 31, 2025 | ||||
| Total purchase consideration: | ||||
| Cash payments | $ | |||
| Holdbacks | ||||
| Less cash acquired | ( | ) | ||
| Total | $ | |||
| Identifiable assets acquired and liabilities assumed: | ||||
| Other acquired assets | ||||
| Inventories | ||||
| Property, plant, and equipment | ||||
| Identifiable intangible assets | ||||
| Goodwill | ||||
| Liabilities assumed | ( | ) | ||
| Total | $ | |||
Minntronix
On July 31, 2023, the Company paid $
The purchase price was allocated to the net tangible and identifiable intangible assets acquired and liabilities assumed based on a valuation of their fair values on the closing date. Goodwill recorded from this transaction is attributable to Minntronix's technical and applications expertise, which is highly complementary to the Company's existing business.
Identifiable intangible assets of $
The components of the fair value of the Minntronix acquisition, including the final allocation of the purchase price are as follows (in thousands):
| Final Allocation as of September 30, 2024 | ||||
| Fair value of business combination: | ||||
| Cash payments | $ | |||
| Less, cash acquired | ( | ) | ||
| Total | $ | |||
| Identifiable assets acquired and liabilities assumed: | ||||
| Other acquired assets | $ | |||
| Customer backlog | ||||
| Inventories | ||||
| Property, plant, & equipment | ||||
| Identifiable intangible assets | ||||
| Goodwill | ||||
| Liabilities assumed | ( | ) | ||
| Total | $ | |||
Acquisition Related Costs
Acquisition related costs include costs related to acquired businesses and other pending acquisitions. These costs consist of (i) deferred compensation arrangements and (ii) acquisition related professional service fees and expenses, including financial advisory, legal, accounting, and other outside services incurred in connection with integration and acquisition activities, and regulatory matters related to acquired entities. These costs do not include purchase accounting expenses, which we define as acquired backlog and the step-up of inventory to fair value, or the amortization of the acquired intangible assets.
Acquisition related costs for the three months ended March 31, 2025 and 2024 were $
3) Revenue From Contracts With Customers
Most of the Company’s contracts have a single performance obligation which represents the product or service being sold to the customer. Some contracts include multiple performance obligations such as a product and the related installation and/or extended warranty. Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications. Assurance type warranties do not represent a separate performance obligation.
In general, the Company recognizes revenue at the point in time control transfers to its customer based on predetermined shipping terms. Revenue is recognized over time under certain long-term contracts within the Engineering Technologies and Engraving segments for highly customized customer products that have no alternative use and in which the contract specifies the Company has a right to payment for its costs, plus a reasonable margin. For products manufactured over time, the transfer of control is measured pro rata, based upon current estimates of costs to complete such contracts. Losses on contracts are fully recognized in the period in which the losses become determinable. Revisions in profit estimates are reflected on a cumulative basis in the period in which the basis for such revision becomes known.
Disaggregation of Revenue from Contracts with Customers
The following table presents revenue from disaggregated by product line and segment (in thousands):
| Three Months Ended | ||||||||
| Revenue by Product Line | March 31, 2025 | March 31, 2024 | ||||||
| Electronics | $ | $ | ||||||
| Engraving Services | ||||||||
| Engraving Products | ||||||||
| Total Engraving | ||||||||
| Scientific | ||||||||
| Engineering Technologies | ||||||||
| Hydraulics Cylinders and Systems | ||||||||
| Merchandising & Display | ||||||||
| Total Specialty Solutions | ||||||||
| Total revenue by product line | $ | $ | ||||||
| Nine Months Ended | ||||||||
| Revenue by Product Line | March 31, 2025 | March 31, 2024 | ||||||
| Electronics | $ | $ | ||||||
| Engraving Services | ||||||||
| Engraving Products | ||||||||
| Total Engraving | ||||||||
| Scientific | ||||||||
| Engineering Technologies | ||||||||
| Hydraulics Cylinders and Systems | ||||||||
| Merchandising & Display | ||||||||
| Total Specialty Solutions | ||||||||
| Total revenue by product line | $ | $ | ||||||
The following table presents revenue from continuing operations disaggregated by geography based on the Company’s locations (in thousands):
| Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | |||||||||||||
| Net sales | March 31, 2025 | March 31, 2024 | March 31, 2025 | March 31, 2024 | ||||||||||||
| United States | $ | $ | $ | $ | ||||||||||||
| Asia Pacific | ||||||||||||||||
| EMEA (1) | ||||||||||||||||
| Other Americas | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
(1) EMEA consists primarily of Europe, Middle East and S. Africa.
The following table presents revenue from continuing operations disaggregated by timing of recognition (in thousands):
| Three Months Ended | ||||||||
| Timing of Revenue Recognition | March 31, 2025 | March 31, 2024 | ||||||
| Products and services transferred at a point in time | $ | $ | ||||||
| Products transferred over time | ||||||||
| Net sales | $ | $ | ||||||
| Nine Months Ended | ||||||||
| Timing of Revenue Recognition | March 31, 2025 | March 31, 2024 | ||||||
| Products and services transferred at a point in time | $ | $ | ||||||
| Products transferred over time | ||||||||
| Net sales | $ | $ | ||||||
Contract Balances
Contract assets represent sales recognized in excess of billings related to work completed but not yet shipped for which revenue is recognized over time. Contract assets are recorded as prepaid expenses and other current assets. Contract liabilities are customer deposits for which revenue has not been recognized. Current contract liabilities are recorded as accrued liabilities.
The timing of revenue recognition, invoicing and cash collections results in billed receivables, contract assets and contract liabilities on the consolidated balance sheets. When consideration is received from a customer prior to transferring goods or services to the customer under the terms of a contract, a contract liability is recorded. Contract liabilities are recognized as revenue after control of the goods and services are transferred to the customer and all revenue recognition criteria have been met.
The following table provides information about contract assets and liability balances (in thousands):
| June 30, 2024 | Additions | Deductions | March 31, 2025 | |||||||||||||
| Nine months ended March 31, 2025 | ||||||||||||||||
| Contract assets: | ||||||||||||||||
| Prepaid expenses and other current assets | $ | $ | $ | $ | ||||||||||||
| Contract liabilities: | ||||||||||||||||
| Customer deposits | ||||||||||||||||
| June 30, 2023 | Additions | Deductions | March 31, 2024 | |||||||||||||
| Nine months ended March 31, 2024 | ||||||||||||||||
| Contract assets: | ||||||||||||||||
| Prepaid expenses and other current assets | $ | $ | $ | $ | ||||||||||||
We recognized the following revenue which was included in the contract liability beginning balances (in thousands):
| March 31, 2025 | March 31, 2025 | |||||||
| Revenue recognized in the period from: | Three months ended | Nine months ended | ||||||
| Amounts included in the contract liability balance at the beginning of the period | $ | $ | ||||||
| March 31, 2024 | March 31, 2024 | |||||||
| Revenue recognized in the period from: | Three months ended | Nine months ended | ||||||
| Amounts included in the contract liability balance at the beginning of the period | $ | $ | ||||||
4) Fair Value Measurements
The financial instruments shown below are presented at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs are not available, valuation models may be applied.
Assets and liabilities recorded at fair value in the consolidated balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities and the methodologies used in valuation are as follows:
Level 1 – Quoted prices (unadjusted) in active markets for identical assets and liabilities. The Company’s deferred compensation plan assets consist of shares in various mutual funds (investments are participant-directed) which invest in a broad portfolio of debt and equity securities. These assets are valued based on publicly quoted market prices for the funds’ shares as of the balance sheet dates.
Level 2 – Inputs, other than quoted prices in an active market, that are observable either directly or indirectly through correlation with market data. For foreign exchange forward contracts and interest rate swaps, the Company values the instruments based on the market price of instruments with similar terms, which are based on spot and forward rates as of the balance sheet dates. The Company has considered the creditworthiness of counterparties in valuing all assets and liabilities.
Level 3 – Unobservable inputs based upon the Company’s best estimate of what market participants would use in pricing the asset or liability.
There were no transfers of assets or liabilities between any levels of the fair value measurement hierarchy at March 31, 2025 or June 30, 2024. The Company’s policy is to recognize transfers between levels as of the date they occur.
Cash and cash equivalents, accounts receivable, accounts payable, and debt are carried at cost, which approximates fair value.
The fair values of financial instruments were as follows (in thousands):
| March 31, 2025 | ||||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | |||||||||||||
| Assets | ||||||||||||||||
| Marketable securities - deferred compensation plan | $ | $ | $ | $ | ||||||||||||
| Foreign exchange contracts | ||||||||||||||||
| Interest rate swaps | ||||||||||||||||
| Debt securities | ||||||||||||||||
| Equity securities | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Contingent consideration (a) | $ | $ | $ | $ | ||||||||||||
| June 30, 2024 | ||||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | |||||||||||||
| Assets | ||||||||||||||||
| Marketable securities - deferred compensation plan | $ | $ | $ | $ | ||||||||||||
| Interest rate swaps | ||||||||||||||||
| Debt securities | ||||||||||||||||
| Equity securities | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Contingent consideration(a) | $ | $ | $ | $ | ||||||||||||
(a) The fair value of our contingent consideration arrangement is determined based on our evaluation as to the probability and amount of any deferred compensation that has been earned to date.
The Company is obligated to pay contingent consideration to the sellers of SEPL in the event that certain financial targets are achieved during the two years following acquisition, which occurred in the fourth quarter of fiscal year 2024. As of March 31, 2025, the maximum liability under this arrangement is $
The Company has determined the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future payments was based on several factors, the most significant of which are the financial performance of the acquired businesses and the risk-adjusted discount rate for the fair value measurement.
Additionally, the Company has financial assets based upon Level 3 inputs, which represent investments in a privately held company.
The Company invested $
In the third quarter of fiscal year 2023, the Company also purchased $
There have been no changes in the fair value of the estimates for the Level 3 assets in fiscal year 2025 other than the impact of foreign exchange, which represents the increase in the fair values from the prior year.
The Company updates its assumptions each reporting period based on new developments and records such amounts at fair value based on the revised assumptions until the agreements expire.
5) Inventories
Inventories from continuing operations are comprised of the following (in thousands):
| March 31, 2025 | June 30, 2024 | |||||||
| Raw materials | $ | $ | ||||||
| Work in process | ||||||||
| Finished goods | ||||||||
| Total | $ | $ | ||||||
Distribution costs associated with the sale of inventory, which are recorded as a component of selling, general and administrative expenses in the accompanying unaudited condensed consolidated statements of operations were $
6) Goodwill
Changes to goodwill by reportable segment during the period were as follows (in thousands):
| June 30, 2024 | Acquisitions | Translation Adjustment | March 31, 2025 | |||||||||||||
| Electronics | $ | $ | $ | $ | ||||||||||||
| Engraving | ||||||||||||||||
| Scientific | ||||||||||||||||
| Engineering Technologies | ||||||||||||||||
| Specialty Solutions | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
7) Warranty Reserves
| March 31, 2025 | June 30, 2024 | |||||||
| Balance at beginning of year | $ | $ | ||||||
| Acquisitions and other charges | ||||||||
| Warranty expense | ||||||||
| Warranty claims | ( | ) | ( | ) | ||||
| Balance at end of period | $ | $ | ||||||
8) Debt
Long-term debt is comprised of the following (in thousands):
| March 31, 2025 | June 30, 2024 | |||||||
| Bank credit agreements | $ | $ | ||||||
| Total funded debt | ||||||||
| Issuance cost | ( | ) | ( | ) | ||||
| Total long-term debt | $ | $ | ||||||
Bank Credit Agreements
During the third quarter of fiscal year 2023, the Company entered into a Third Amended & Restated Credit Agreement which renewed the existing Credit Agreement for an additional -year period (“Credit Facility”, or “Facility”). The Facility has a borrowing limit of $
During the second quarter of fiscal year 2025, the Company entered into a $
At March 31, 2025, the Company had standby letters of credit outstanding, primarily for insurance purposes, of $
9) Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
| March 31, 2025 | June 30, 2024 | |||||||
| Payroll and employee benefits | $ | $ | ||||||
| Operating lease current liability | ||||||||
| Accrued taxes payable | ||||||||
| Accrued interest | ||||||||
| Warranty reserves | ||||||||
| Restructuring costs | ||||||||
| Workers' compensation | ||||||||
| Contingent consideration | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
Prior year components of accrued taxes payable and accrued interest have been conformed to current year presentation.
10) Derivative Financial Instruments
The Company is exposed to market risks from changes in interest rates, commodity prices and changes in foreign currency rates. The Company selectively uses derivative financial instruments in order to manage certain of these risks. Information about the Company’s derivative financial instruments is as follows:
Interest Rate Swaps
From time to time as dictated by market opportunities, the Company enters into interest rate swap agreements designed to manage exposure to interest rates on the Company’s variable rate indebtedness. The Company recognizes all derivatives on its consolidated balance sheets at fair value. The Company has designated its interest rate swap agreements, including those that may be forward-dated, as cash flow hedges, and changes in the fair value of the swaps are recognized in accumulated other comprehensive income until the hedged items are recognized in earnings. Hedge ineffectiveness, if any, associated with the swaps is reported in earnings within interest expense.
The Company’s effective swap agreements convert the base borrowing rate on $
| Effective Date | Notional Amount | Fixed Interest Rate | Maturity | March 31, 2025 | June 30, 2024 | ||||||||||||
| February 23, 2023 | % |
| $ | $ | |||||||||||||
| May 25, 2023 | % |
| |||||||||||||||
| February 24, 2023 | % |
| |||||||||||||||
| $ | $ | ||||||||||||||||
The Company reported
Foreign Exchange Contracts
Forward foreign currency exchange contracts are used to limit the impact of currency fluctuations on certain anticipated foreign cash flows, such as collections from customers and loan payments between subsidiaries. The Company enters into such contracts for hedging purposes only. At March 31, 2025 and June 30, 2024, the Company had outstanding forward contracts related to hedges of intercompany loans with net unrealized losses and gains of less than $
The notional amounts of the Company’s forward contracts, by currency, are as follows (in thousands):
| Currency | March 31, 2025 | June 30, 2024 | ||||
| USD | ||||||
| CAD | ||||||
| JPY |
| Asset Derivatives | ||||||||||
| March 31, 2025 | June 30, 2024 | |||||||||
| Derivative designated | Balance Sheet | Balance Sheet | ||||||||
| as hedging instruments | Line Item | Fair Value | Line Item | Fair Value | ||||||
| Interest rate swaps | Other Assets | $ | Other Assets | $ | ||||||
| Liability Derivatives | ||||||||||
| March 31, 2025 | June 30, 2024 | |||||||||
| Derivative designated | Balance Sheet | Balance Sheet | ||||||||
| as hedging instruments | Line Item | Fair Value | Line Item | Fair Value | ||||||
| Foreign exchange contracts | Accrued liabilities | $ | Accrued liabilities | $ | ||||||
The table below presents the amount of gain (loss) recognized in comprehensive income on our derivative financial instruments (effective portion) designated as hedging instruments and their classification within comprehensive income for the periods ended (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Interest rate swaps | $ | $ | $ | ( | ) | $ | ||||||||||
| Foreign exchange contracts | ||||||||||||||||
| $ | $ | $ | ( | ) | $ | |||||||||||
The table below presents the amount reclassified from accumulated other comprehensive income (loss) to net income for the periods ended (in thousands):
| Details about Accumulated | Affected line item | ||||||||||||||||
| Other Comprehensive | Three Months Ended | Nine Months Ended | in the Unaudited | ||||||||||||||
| Income (Loss) Components | March 31, | March 31, | Condensed Statements | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | of Operations | |||||||||||||
| Interest rate swaps | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | Interest expense | ||||
| Foreign exchange contracts | ( | ) | Other non-operating (income) expense, net | ||||||||||||||
| $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
11) Retirement Benefits
The Company has defined benefit pension plans covering certain current and former employees both inside and outside of the U.S. The Company’s pension plan for U.S. employees is frozen for substantially all participants and has been replaced with a defined contribution benefit plan.
Net periodic benefit cost for the Company’s U.S. and foreign pension benefit plans for the periods ended consisted of the following components (in thousands):
| U.S. Plans | Non-U.S. Plans | |||||||||||||||
| Three Months Ended | Three Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Service cost | $ | $ | $ | $ | ||||||||||||
| Interest cost | ||||||||||||||||
| Expected return on plan assets | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Recognized net actuarial loss | ( | ) | ||||||||||||||
| Amortization of prior service cost | ( | ) | ( | ) | ||||||||||||
| Net periodic (benefit) cost | $ | $ | $ | $ | ( | ) | ||||||||||
| U.S. Plans | Non-U.S. Plans | |||||||||||||||
| Nine Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Service cost | $ | $ | $ | $ | ||||||||||||
| Interest cost | ||||||||||||||||
| Expected return on plan assets | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Recognized net actuarial loss | ( | ) | ||||||||||||||
| Amortization of prior service cost | ( | ) | ( | ) | ||||||||||||
| Net periodic (benefit) cost | $ | $ | $ | $ | ( | ) | ||||||||||
The following table sets forth the amounts recognized for the Company's defined benefit pension plans (in thousands):
| Amounts recognized in the consolidated balance sheets consist of: | March 31, 2025 | June 30, 2024 | ||||||
| Prepaid benefit cost | $ | $ | ||||||
| Current liabilities | ( | ) | ( | ) | ||||
| Non-current liabilities | ( | ) | ( | ) | ||||
| Net amount recognized | $ | ( | ) | $ | ( | ) | ||
The contributions made to defined benefit plans are presented below along with remaining contributions to be made for fiscal year 2025 (in thousands):
| Fiscal Year 2025 | Fiscal Year 2024 | Remaining | ||||||||||||||||||
| Three Months Ended | Nine Months Ended | Three Months Ended | Nine Months Ended | Contributions | ||||||||||||||||
| Contributions to defined benefit plans | March 31, 2025 | March 31, 2025 | March 31, 2024 | March 31, 2024 | FY 2025 | |||||||||||||||
| United States, funded plan | $ | $ | $ | $ | $ | |||||||||||||||
| United States, unfunded plan | ||||||||||||||||||||
| Germany, unfunded plan | ||||||||||||||||||||
| $ | $ | $ | $ | $ | ||||||||||||||||
12) Income Taxes
The Company's effective tax rate from continuing operations for the third quarter of fiscal year 2025 and for the first nine months of fiscal year 2025 was (
The tax rate was impacted for the third quarter of fiscal year 2025 and for the first nine months of fiscal year 2025 by the following items: (i) a discrete tax benefit related to the release of a previously recorded tax reserve for a one-time tax charge on historical foreign earnings, as the relevant statute of limitations expired during the quarter, (ii) the jurisdictional mix of earnings, (iii) foreign withholding taxes and (iv) federal research and development tax credits.
The tax rate was impacted in the prior year quarter and prior year period, respectively by the following items: (i) a discrete tax expense related to provision to return adjustments associated with federal research and development tax credits and the limitation on executive compensation, (ii) the jurisdictional mix of earnings and (iii) a discrete tax benefit related to foreign withholding taxes.
13) Earnings Per Share
The Company uses shares acquired through treasury stock repurchases for the issuance of shares of common stock for the settlement of awards under its stock-based compensation plans, with the net effect of these transactions accounting for the change in common stock outstanding.
The following table sets forth a reconciliation of the number of shares (in thousands) used in the computation of basic and diluted earnings per share:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| March 31, | March 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Basic - Average shares outstanding | ||||||||||||||||
| Dilutive effect of unvested, restricted stock awards | ||||||||||||||||
| Diluted - Average shares outstanding | ||||||||||||||||
Earnings available to common stockholders are the same for computing both basic and diluted earnings per share. There were
Performance stock units of
14) Accumulated Other Comprehensive Income (Loss)
The components of the Company’s accumulated other comprehensive income (loss) are as follows (in thousands):
| March 31, 2025 | June 30, 2024 | |||||||
| Foreign currency translation adjustment | $ | ( | ) | $ | ( | ) | ||
| Unrealized pension losses, net of tax | ( | ) | ( | ) | ||||
| Unrealized gains on derivative instruments, net of tax | ||||||||
| Total | $ | ( | ) | $ | ( | ) | ||
15) Contingencies
From time to time, the Company is subject to various claims and legal proceedings, including claims related to environmental remediation, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of these proceedings and claims cannot be predicted with certainty, the Company’s management does not believe that the outcome of any of the currently existing legal matters will have a material impact on the Company’s consolidated financial position, results of operations or cash flow. The Company accrues for losses related to a claim or litigation when the Company’s management considers a potential loss probable and can reasonably estimate such potential loss.
16) Industry Segment Information
The Company has reportable segments organized around the types of products sold:
| • | Electronics – manufactures and sells electronic components for applications throughout the end user market spectrum; | |
| • | Engraving – provides mold texturizing, slush molding tools, project management and design services, roll engraving, hygiene product tooling, low observation vents for stealth aircraft, and process machinery for a number of industries; | |
| • | Scientific – sells specialty temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech and industrial markets; | |
| • | Engineering Technologies – provides net and near net formed single-source customized solutions in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets; | |
| • | Specialty Solutions – an aggregation of two operating segments that manufacture and sell refrigerated, heated and dry merchandizing display cases and single and double acting telescopic and piston rod hydraulic cylinders. |
Net sales and income (loss) from continuing operations by segment were as follows (in thousands):
| Three Months Ended March 31, | ||||||||||||||||
| Net Sales | Income from Operations | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Industry segment: | ||||||||||||||||
| Electronics | $ | $ | $ | $ | ||||||||||||
| Engraving | ||||||||||||||||
| Scientific | ||||||||||||||||
| Engineering Technologies | ||||||||||||||||
| Specialty Solutions | ||||||||||||||||
| Corporate | - | - | ( | ) | ( | ) | ||||||||||
| Restructuring costs | - | - | ( | ) | ( | ) | ||||||||||
| Acquisition related costs | - | - | ( | ) | ( | ) | ||||||||||
| Other operating income (expense), net | - | - | ( | ) | ||||||||||||
| Sub-total | $ | $ | $ | $ | ||||||||||||
| Interest expense | ||||||||||||||||
| Other non-operating (income) expense | ||||||||||||||||
| Income from continuing operations before income taxes | $ | $ | ||||||||||||||
| Nine Months Ended March 31, | ||||||||||||||||
| Net Sales | Income from Operations | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Industry segment: | ||||||||||||||||
| Electronics | $ | $ | $ | $ | ||||||||||||
| Engraving | ||||||||||||||||
| Scientific | ||||||||||||||||
| Engineering Technologies | ||||||||||||||||
| Specialty Solutions | ||||||||||||||||
| Corporate | - | - | ( | ) | ( | ) | ||||||||||
| Restructuring costs | - | - | ( | ) | ( | ) | ||||||||||
| Gain on sale of business | - | - | ||||||||||||||
| Acquisition related costs | - | - | ( | ) | ( | ) | ||||||||||
| Other operating income (expense), net | - | - | ( | ) | ||||||||||||
| Sub-total | $ | $ | $ | $ | ||||||||||||
| Interest expense | ||||||||||||||||
| Other non-operating (income) expense | ||||||||||||||||
| Income from continuing operations before income taxes | $ | $ | ||||||||||||||
Net sales include only transactions with unaffiliated customers and include no intersegment sales. Income (loss) from operations by segment excludes interest expense and other non-operating (income) expense.
17) Restructuring
The Company has undertaken a number of initiatives that have resulted in severance, restructuring, and related charges. Related charges may include third party assistance with analysis and implementation of these activities.
2025 Restructuring Initiatives
The Company continues to focus its efforts to reduce cost and improve productivity across its businesses. Restructuring expenses primarily related to facility rationalizations and consolidations. The Company expects the 2025 restructuring activities to be completed by fiscal year 2026.
Prior Year Restructuring Initiatives
Restructuring expenses primarily related to headcount reductions and other cost saving initiatives within our Engraving and Electronics segments. The Company expects the prior year restructuring activities to be completed by fiscal year 2025.
A summary of charges by initiative is as follows (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
| March 31, 2025 | March 31, 2025 | |||||||||||||||||||||||
| Fiscal Year 2025 | Involuntary Employee Severance and Benefit Costs | Other | Total | Involuntary Employee Severance and Benefit Costs | Other | Total | ||||||||||||||||||
| Current year initiatives | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Prior year initiatives | $ | |||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | |||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
| March 31, 2024 | March 31, 2024 | |||||||||||||||||||||||
| Fiscal Year 2024 | Involuntary Employee Severance and Benefit Costs | Other | Total | Involuntary Employee Severance and Benefit Costs | Other | Total | ||||||||||||||||||
| Current year initiatives | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Prior year initiatives | ||||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | |||||||||||||||||||
Activity in the restructuring liability reserve related to the initiatives is as follows (in thousands):
| Current Year Initiatives | Involuntary Employee Severance and Benefit Costs | Other | Total | |||||||||
| Restructuring liabilities at June 30, 2024 | $ | $ | $ | |||||||||
| Additions and adjustments | ||||||||||||
| Payments | ( | ) | ( | ) | ( | ) | ||||||
| Restructuring liabilities at March 31, 2025 | $ | $ | $ | |||||||||
| Prior Year Initiatives | Involuntary Employee Severance and Benefit Costs | Other | Total | |||||||||
| Restructuring liabilities at June 30, 2024 | $ | $ | $ | |||||||||
| Additions and adjustments | ||||||||||||
| Payments | ( | ) | ( | ) | ( | ) | ||||||
| Restructuring liabilities at March 31, 2025 | $ | $ | $ | |||||||||
| Prior Year | Involuntary Employee Severance and Benefit Costs | Other | Total | |||||||||
| Restructuring liabilities at June 30, 2023 | $ | $ | $ | |||||||||
| Additions and adjustments | ||||||||||||
| Payments | ( | ) | ( | ) | ( | ) | ||||||
| Restructuring liabilities at March 31, 2024 | $ | $ | $ | |||||||||
The Company’s total restructuring expenses by segment are as follows (in thousands):
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
| March 31, 2025 | March 31, 2025 | |||||||||||||||||||||||
| Involuntary Employee Severance and Benefit Costs | Other | Total | Involuntary Employee Severance and Benefit Costs | Other | Total | |||||||||||||||||||
| Engraving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Electronics | ||||||||||||||||||||||||
| Corporate | ||||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | |||||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
| March 31, 2024 | March 31, 2024 | |||||||||||||||||||||||
| Involuntary Employee Severance and Benefit Costs | Other | Total | Involuntary Employee Severance and Benefit Costs | Other | Total | |||||||||||||||||||
| Electronics | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Engraving | ||||||||||||||||||||||||
| Engineering Technologies | ||||||||||||||||||||||||
| Corporate | ||||||||||||||||||||||||
| $ | $ | $ | $ | $ | $ | |||||||||||||||||||
Restructuring expense is expected to be approximately $
18) Redeemable Noncontrolling Interest
The redeemable noncontrolling interest represents the minority shareholder's interest in NPPL, which was acquired as part of the Amran/Narayan Group Acquisition in the second quarter of fiscal year 2025. The Company entered into a Shareholder Agreement that provides the Company with the right to purchase, and the noncontrolling interest holders with the right to sell, their remaining minority interest at a contractually defined redemption value. As the redemptions are contingently redeemable at the option of the noncontrolling interest shareholders, the Company classifies the redeemable noncontrolling interest in the mezzanine equity section on the consolidated balance sheets, which is presented above the equity section and below liabilities. The repurchase price of the redeemable noncontrolling interests is the greater of the share price paid for similar shares as part of the Amran/Narayan Acquisition or 12 times twelve months' trailing EBITDA.
In accounting for the subsequent measurement of the redeemable noncontrolling interest measurement adjustments pursuant to ASC 480, Distinguishing Liabilities from Equity, the Company has made accounting policy elections to record any such applicable changes on the immediate recognition of the full adjustment required to report the redeemable noncontrolling interest at its redemption value, while also electing to record such adjustments under the income method, with a corresponding offset recorded to the Net income attributable to noncontrolling interests in consolidated subsidiaries within the consolidated statement of operations for the period in which such measurement adjustment becomes required. Given the pending approval of the RBI for the second closing and share swap, the noncontrolling interest is not probable of redemption as of March 31, 2025, and accordingly no measurement adjustments have been recorded for the three and nine months ended March 31, 2025.
19) Transactions with Related Parties of Amran/Narayan Group
The Amran/Narayan Group, acquired in the second quarter of fiscal year 2025, has certain transactions with parties affiliated with current and former shareholders of the Amran/Narayan Group, including the current President of the Amran/Narayan Group entities in India. The transactions with these parties continue and are summarized as follows:
| Names of Related Parties | Relationship with the Amran/Narayan Group |
| Narayan Epoxy Components Private Limited | Entity controlled by minority shareholders of Narayan |
| Gujarat Plug In Devices Private Limited | Narayan minority shareholders have significant ownership interest |
| Narayanshree Infrastructure LLP | Partners are former and current minority shareholders of Narayan |
| Narayan Minority Shareholders | Lessors of certain real property |
At March 31, 2025, $
| Fiscal Year | Amount | |||
| Remainder of 2025 | $ | |||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| 2029 | ||||
| Thereafter | ||||
20) Divestitures
On February 28, 2023, the Company divested its Procon pumps business (“Procon”) to Investindustrial, a leading European investment and advisory group. Procon generated approximately $
The Company received $
During the first quarter of fiscal year 2024, the Company recorded an additional $
| Management's Discussion and Analysis of Financial Condition and Results of Operations |
Forward-Looking Statements
Statements contained in this periodic report that are not based on historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as “should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company’s business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of pandemics and other global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the “Risk Factors” section of the Company’s most recent annual report on Form 10-K filed with the SEC and available on the Company’s website. In addition, any forward-looking statements represent management's estimates only as of the day made and should not be relied upon as representing management's estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management's estimates change.
Overview
We are a diversified industrial manufacturer with leading positions in a variety of products and services that are used in diverse commercial and industrial markets. Headquartered in Salem, New Hampshire, we have six operating segments aggregated into five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. Two operating segments are aggregated into Specialty Solutions. Our businesses work in close partnership with our customers to deliver custom solutions or engineered components that solve their unique and specific needs, an approach we call "Customer Intimacy".
Our long-term business strategy is to create, improve, and enhance shareholder value by building more profitable, focused industrial platforms through our Standex Value Creation System. This methodology employs four components: Balanced Performance Plan, Growth Disciplines, Operational Excellence, and Talent Management and provides both a company-wide framework and tools used to achieve our goals. We intend to continue investing organically and inorganically in high margin and growth businesses using this balanced and proven approach.
It is our objective to grow larger and more profitable business units through a commitment to both organic and inorganic initiatives. We have a particular focus on identifying and investing in businesses, new products and new applications that complement our existing products and will increase our overall scale, global presence and capabilities. We continue to execute on acquisitions where strategically aligned with our businesses and where the opportunity meets our investment metrics. We have divested, and likely will continue to divest, businesses that we feel are not strategic or do not meet our growth and return expectations.
As part of our ongoing strategy:
| • |
On February 4, 2025, we acquired McStarlite Co., a leading provider of complex sheet metal aerospace components, financed from our existing Credit Facility. Its results are reported in the Engineering Technologies segment beginning in the third quarter of fiscal year 2025. |
| • |
On November 18, 2024, we acquired Nascent Technology Manufacturing, which designs and produces high-reliability magnetics components for critical defense and industrial application. Its results are reported in the Electronics segment beginning in the second quarter of fiscal year 2025. |
| • | On November 14, 2024, we acquired Custom Biogenic Systems, it specializes in the development and manufacturing of advanced cryogenic equipment, including unique Isothermal freezers with dry liquid nitrogen technology, to the pharmaceutical and biobank end markets within life sciences. Its results are reported in the Scientific segment beginning in the second quarter of fiscal year 2025. |
| • | On October 28, 2024, we acquired the Amran/Narayan Group in cash and stock transactions. These transactions represent a combined enterprise value of approximately $467.5 million, comprised of 85% cash and 15% in Standex common stock for Amran Instrument Transformers and 90% cash and 10% in Standex common stock for Narayan Powertech Pvt. Ltd. The 10% share exchange related to Narayan Powertech Pvt. Ltd. is subject to India regulatory approval, which is expected to take up to six months. The cash consideration of the transactions was financed using cash-on-hand, existing credit facilities, and a $250 million 364-day term loan with existing lenders. We converted the 364-day term loan into an exercise of the accordion feature under our existing credit facilities. This acquisition significantly expands our sales in the fast-growing, high-margin electrical grid end market and our presence in India. Its results are reported in the Electronics segment beginning in the second quarter of fiscal year 2025. |
| • | On May 3, 2024, we acquired Sanyu Electric Pte Ltd, or SEPL, a privately held distributor of reed relays. Its results are reported in the Electronics segment. |
| • |
On February 19, 2024, we acquired, through our subsidiary Standex Electronics Japan Corporation, privately-held, Japanese-based Sanyu Switch Co., Ltd (Sanyu). Sanyu designs and manufactures reed relays, test sockets, testing systems for semiconductor and other electronics manufacturing, and other switching applications. Its results are reported in the Electronics segment. |
| • |
On July 31, 2023, we acquired Minntronix, a privately held company. Minntronix designs and manufactures customized as well as standard magnetics components and products including transformers, inductors, current sensors, coils, chokes, and filters. The products are used in applications across cable fiber, smart meters, industrial control and lighting, electric vehicles, and home security markets. Its results are reported in the Electronics segment. |
As a result of our portfolio moves over the past several years, we have transformed Standex to a company with a more focused group of businesses selling customized solutions to high value end markets via a compelling customer value proposition. The narrowing of the portfolio allows for greater management focus on driving operational disciplines and positions us well to use our cash flow from operations to invest selectively in our ongoing pipeline of organic and inorganic opportunities.
The Company’s strong historical cash flow has been a cornerstone for funding our capital allocation strategy. We use cash flow generated from operations to fund investments in capital assets to upgrade our facilities, improve productivity and lower costs, invest in the strategic growth programs described above, including organic growth and acquisitions, and to return cash to our shareholders through payment of dividends and stock buybacks.
Restructuring expenses reflect costs associated with our efforts of continuously improving operational efficiency and expanding globally in order to remain competitive in our end user markets. We incur costs for actions to size our businesses to a level appropriate for current economic conditions, improve our cost structure, enhance our competitive position and increase operating margins. Such expenses include costs for moving facilities to locations that allow for lower fixed and variable costs, external consultants who provide additional expertise starting up plants after relocation, downsizing operations because of changing economic conditions, and other costs resulting from asset redeployment decisions. Shutdown costs include severance, benefits, stay bonuses, lease and contract terminations, asset write-downs, costs of moving fixed assets, and moving and relocation costs. Vacant facility costs include maintenance, utilities, property taxes and other costs.
Because of the diversity of the Company’s businesses, end user markets and geographic locations, management does not use specific external indices to predict the future performance of the Company, other than general information about broad macroeconomic trends. Each of our individual business units serves niche markets and attempts to identify trends other than general business and economic conditions which are specific to its business and which could impact its performance. Those units report pertinent information to senior management, which uses it to the extent relevant to assess the future performance of the Company. A description of any such material trends is described below in the applicable segment analysis.
We monitor a number of key performance indicators (“KPIs”) including net sales, income from operations, backlog, effective income tax rate, gross profit margin, and operating cash flow. A discussion of these KPIs is included below. We may also supplement the discussion of these KPIs by identifying the impact of foreign exchange rates, acquisitions, and other significant items when they have a material impact on a specific KPI.
We believe the discussion of these items provides enhanced information to investors by disclosing their impact on the overall trend which provides a clearer comparative view of the KPI, as applicable. For discussion of the impact of foreign exchange rates on KPIs, we calculate the impact as the difference between the current period KPI calculated at the current period exchange rate as compared to the KPI calculated at the historical exchange rate for the prior period. For discussion of the impact of acquisitions, we isolate the effect on the KPI amount that would have existed regardless of such acquisition. Sales resulting from synergies between the acquisition and existing operations of the Company are considered organic growth for the purposes of our discussion.
Unless otherwise noted, references to years are to fiscal years.
Results from Continuing Operations
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| March 31, |
March 31, |
|||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
2025 |
2024 |
||||||||||||
| Net sales |
$ | 207,780 | $ | 177,267 | $ | 568,058 | $ | 540,441 | ||||||||
| Gross profit margin |
39.7 | % | 38.5 | % | 39.4 | % | 39.3 | % | ||||||||
| Income from operations |
26,253 | 21,842 | 58,815 | 74,591 | ||||||||||||
| Three Months Ended |
Nine Months Ended |
|||||||
| (In thousands) |
March 31, 2025 |
March 31, 2025 |
||||||
| Net sales, prior year period |
$ | 177,267 | $ | 540,441 | ||||
| Components of change in sales: |
||||||||
| Organic sales change |
(14,407 | ) | (50,189 | ) | ||||
| Effect of acquisitions |
46,661 | 80,866 | ||||||
| Effect of exchange rates |
(1,741 | ) | (3,060 | ) | ||||
| Net sales, current period |
$ | 207,780 | $ | 568,058 | ||||
Net sales increased in the third quarter of fiscal year 2025 by $30.5 million or 17.2%, when compared to the prior year quarter. The recent acquisitions positively impacted sales by $46.7 million, or 26.3%. Organic sales decreased $14.4 million, or 8.1%, due to lower demand in the automotive end market in our Engraving and Electronics segments in North America and Europe, and continued softness in general industrial end markets. These decreases were partially offset by favorable project timing in our Engineering Technologies segment. Organic sales in the third quarter of fiscal year 2025 included $60.4 million attributed to fast growth markets. Foreign currency negatively impacted sales by $1.7 million, or 1.0%.
Net sales decreased in the nine months ended March 31, 2025 by $27.6 million or 5.1%, when compared to the prior year period. Organic sales decreased $50.2 million, or 9.3%, due to lower demand in the automotive end market our Engraving and Electronics segments in North America and Europe and continued softness in general industrial end markets. These decreases were partially offset by strong demand and favorable project timing in our Engineering Technologies segment. Organic sales in the first nine months of fiscal year 2025 included $123.1 million attributed to fast growth markets. The recent acquisitions positively impacted sales by $80.9 million, or 15.0%. Foreign currency negatively impacted sales by $3.1 million, or 0.6%.
Gross Profit
Gross profit in the third quarter of fiscal year 2025 increased to $82.4 million, or a gross margin of 39.7% as compared to $68.3 million, or a gross margin of 38.5%, in the third quarter of fiscal year 2024. Gross profit was impacted by the organic sales decreases, $2.2 million in purchase accounting expenses in connection with our recent acquisitions and approximately $1.6 million of net inflationary impacts in the areas of labor and materials, partially offset by productivity initiatives and contribution from recent acquisitions.
Gross profit in the nine months ended March 31, 2025 increased to $223.9 million or a gross margin of 39.4% as compared to $212.5 million or a gross margin of 39.3% in the nine months ended March 31, 2024. Gross profit was impacted by the organic sales decreases, $20.4 million in purchase accounting expenses in connection with our recent acquisitions and approximately $5.2 million of net inflationary impacts in the areas of labor and materials, partially offset by productivity initiatives and contribution from recent acquisitions.
Selling, General, and Administrative Expenses
Selling, General, and Administrative (“SG&A”) expenses for the third quarter of fiscal year 2025 were $52.0 million, or 25.1% of sales, compared to $41.8 million, or 23.6% of sales, during the prior year quarter.
Selling, General, and Administrative (“SG&A”) expenses for the nine months ended March 31, 2025 were $140.7 million, or 24.8% of sales, compared to $128.6 million, or 23.8% of sales, during the prior year period. The increase in SG&A expenses during the relevant periods primarily results from the impact of the recent acquisitions.
Restructuring Costs
We incurred restructuring expenses of $2.0 million in the third quarter of fiscal year 2025, and $4.0 million in the first nine months of fiscal year 2025 primarily related to facility closures and global headcount reductions within our Engraving and Electronics segments.
We expect to incur restructuring costs of approximately $1.0 million throughout the remainder of fiscal year 2025, as we continue to focus our efforts to reduce costs and improve productivity across our businesses.
Acquisition Related Costs
We incurred acquisition related expenses of $2.2 million in the third quarter of fiscal year 2025 and $20.4 million in the first nine months of fiscal year 2025. Acquisition related expenses typically consist of due diligence, advisory, legal, integration, and valuation expenses incurred in connection with recent or pending acquisitions.
Gain on Sale of Business
We recorded a pre-tax gain on sale of the Procon business of $62.1 million for fiscal year 2023. In the first quarter of fiscal year 2024, we recorded an additional $0.3 million gain on the sale related to closing cash adjustments. The sale transaction and financial results of Procon are classified as continuing operations in the Consolidated Financial Statements.
Income from Operations
Income from operations for the third quarter of fiscal year 2025 was $26.3 million, compared to $21.8 million during the prior year quarter. The increase of $4.4 million, or 20.2%, is primarily due to contributions from recent acquisitions and productivity improvement initiatives, partially offset by lower organic sales and acquisition related costs.
Income from operations for the nine months ended March 31, 2025 was $58.8 million compared to $74.6 million during the prior year period. The decrease of $15.8 million or 21.2%, is primarily due to lower organic sales and acquisition related costs. The decreases are partially offset by contributions from recent acquisitions and productivity improvement initiatives.
Interest Expense
Interest expense for the third quarter of fiscal year 2025 was $8.4 million, an increase from interest expense of $0.9 million during the prior year quarter. Interest expense for the nine months ended March 31, 2025 was $14.9 million an increase from interest expense of $3.2 million during the prior year period. Our effective interest rate for the nine months ended March 31, 2025 was 6.00%.
Income Taxes
The Company's effective tax rate from continuing operations for the third quarter of fiscal year 2025 and for the nine months ended March 31, 2025 was 29.6% and 1.1% compared with 21.4% and 22.5% for the prior year quarter and prior year period, respectively. The tax rate was impacted in the current period by the following items: (i) a discrete tax benefit related to the release of a previously recorded tax reserve for a one-time tax charge on historical foreign earnings, as the relevant statute of limitations expired during the quarter, (ii) the jurisdictional mix of earnings, (iii) foreign withholding taxes and (iv) federal research and development tax credits.
The tax rate was impacted in the prior period by the following items: (i) a discrete tax expense related to provision to return adjustments associated with federal research and development tax credits and the limitation on executive compensation, (ii) the jurisdictional mix of earnings and (iii) a discrete tax benefit related to foreign withholding taxes.
Backlog
Backlog includes all active or open orders for goods and services. Backlog also includes any future deliveries based on executed customer contracts, so long as such deliveries are based on agreed upon delivery schedules. Backlog orders are not necessarily an indicator of future sales levels because of variations in lead times and customer production demand pull systems, with the exception of Engineering Technologies. Customers may delay delivery of products or cancel orders prior to shipment, subject to possible cancellation penalties. Due to the nature of long-term agreements in the Engineering Technologies segment, the timing of orders and delivery dates can vary considerably resulting in significant backlog changes from one period to another.
| As of March 31, 2025 |
As of March 31, 2024 |
|||||||||||||||
| Total Backlog |
Backlog under 1 year |
Total Backlog |
Backlog under 1 year |
|||||||||||||
| Electronics |
$ | 140,971 | $ | 129,224 | $ | 116,150 | $ | 106,603 | ||||||||
| Engraving |
18,196 | 17,937 | 25,389 | 23,102 | ||||||||||||
| Scientific |
3,787 | 3,787 | 2,809 | 2,809 | ||||||||||||
| Engineering Technologies |
90,238 | 81,906 | 61,791 | 47,424 | ||||||||||||
| Specialty Solutions |
17,118 | 17,054 | 19,236 | 19,236 | ||||||||||||
| Total |
$ | 270,310 | $ | 249,908 | $ | 225,375 | $ | 199,174 | ||||||||
Total backlog realizable under one year increased $50.7 million, or 25.5%, to $249.9 million at March 31, 2025, from $199.2 million at March 31, 2024. The year over year increase is primarily driven by an additional $71.6 million in backlog for the recent acquisitions in the Electronics and Engineering Technologies segments.
Changes in backlog under one year are as follows (in thousands):
| As of |
||||
| (In thousands) |
March 31, 2025 |
|||
| Backlog under 1 year, prior year period |
$ | 199,174 | ||
| Components of change in backlog: |
||||
| Organic change |
(20,881 | ) | ||
| Effect of acquisitions |
71,615 | |||
| Backlog under 1 year, current period |
$ | 249,908 | ||
Segment Analysis
Overall
Looking forward to the remainder of fiscal year 2025, we anticipate continued improvement in key financials metrics, supported by productivity initiatives.
In general, for the remainder of fiscal year 2025, we expect:
| • |
increased exposure to the high growth, high margin electrical grid end market as a result of the Amran/Narayan Group acquisition; |
| • |
commercial aviation and defense end markets demand to increase based on current program expectations and new product development; |
| • |
space markets to remain attractive, with volume to slightly increase from fiscal year 2024 due to new product development for existing customers; |
| • |
continued stability in hybrid and electric vehicle programs despite softness in general automotive end markets and planned new platform launches; |
| • |
scientific cold storage demand to decline due to anticipated effects of potential NIH funding cuts; |
| • |
refuse and dump end markets to remain stable; |
| • |
stable demand levels in food service equipment markets. |
Electronics Group
| Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| March 31, |
% |
March 31, |
% |
|||||||||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
Change |
2025 |
2024 |
Change |
||||||||||||||||||
| Net sales |
$ | 111,283 | $ | 80,431 | 38.4 | % | $ | 284,939 | $ | 241,538 | 18.0 | % | ||||||||||||
| Income from operations |
25,471 | 15,700 | 62.2 | % | 59,918 | 47,884 | 25.1 | % | ||||||||||||||||
| Operating income margin |
22.9 | % | 19.5 | % | 21.0 | % | 19.8 | % | ||||||||||||||||
Net sales in the third quarter of fiscal year 2025 increased $30.9 million, or 38.4%, when compared to the prior year quarter. The recent acquisitions added $38.7 million, or 48.1%, in sales for the third quarter of fiscal year 2025. An organic sales decrease of $7.2 million, or 8.9%, and foreign currency impacts of $0.6 million, or 0.8%, negatively affected net sales compared to the prior year quarter. The organic sales decline was due to continued softness in the automotive end markets in Europe and North America and in general industrial end markets.
Income from operations in the third quarter of fiscal year 2025 increased by $9.8 million, or 62.2%, when compared to the prior year quarter. The operating income increase was the result of contributions from the recent acquisitions, productivity initiatives and product mix, partially offset by lower organic sales.
Net sales in the nine months ended March 31, 2025 increased $43.4 million, or 18.0%, when compared to the prior year period. The recent acquisitions added $71.4 million, or 29.6%, in net sales for the first nine months of fiscal 2025. An organic sales decrease of $26.8 million, or 11.1%, and foreign currency impacts of $1.1 million, or 0.4%, negatively affected net sales compared to the prior year period. The organic sales decline was due to softness in the automotive end markets in Europe and North America and in general industrial end markets, and the effect of prior overstocking related to certain large customer accounts.
Income from operations in the nine months ended March 31, 2025 increased by $12.0 million, or 25.1%, when compared to the prior year period. The operating income increase was the result of contributions from the recent acquisitions, productivity initiatives and product mix, partially offset by lower organic sales.
In the fourth quarter of fiscal year 2025, on a sequential basis, we expect slightly higher revenue and similar to slightly higher operating margin, primarily driven by contributions from the Amran/Narayan acquisition, higher sales into fast growth end markets, and price realizations, partially offset by higher tariff cost and continued strategic growth investments.
Engraving Group
| Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| March 31, |
% |
March 31, |
% |
|||||||||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
Change |
2025 |
2024 |
Change |
||||||||||||||||||
| Net sales |
$ | 30,585 | $ | 36,297 | (15.7 | %) | $ | 95,402 | $ | 117,936 | (19.1 | %) | ||||||||||||
| Income from operations |
3,058 | 6,260 | (51.2 | %) | 13,004 | 22,765 | (42.9 | %) | ||||||||||||||||
| Operating income margin |
10.0 | % | 17.2 | % | 13.6 | % | 19.3 | % | ||||||||||||||||
Net sales in the third quarter of fiscal year 2025 decreased by $5.7 million, or 15.7%, when compared to the prior year quarter. Organic sales decreased by $4.6 million, or 12.7%, due to continued softness in North America from delays in new platform rollouts. Foreign currency negative impacts on net sales were $1.1 million, or 3.0%.
Income from operations in the third quarter of fiscal year 2025 decreased by $3.2 million, or 51.2%, when compared to the prior year quarter. The operating income decrease was driven by organic sales decreases due to lower demand, partially offset by the realization of previously announced productivity initiatives and restructuring actions.
Net sales in the nine months ended March 31, 2025 decreased by $22.5 million, or 19.1%, when compared to the prior year period. The decrease is primarily driven by delays in new platform rollouts in North America and general market softness.
Income from operations in the nine months ended March 31, 2025 decreased by $9.8 million, or 42.9%, when compared to the prior year period primarily driven by lower demand and project mix, partially offset by the realization of previously announced productivity initiatives and restructuring actions.
In the fourth quarter of fiscal year 2025, on a sequential basis, we expect slightly higher revenue and moderately higher operating margin due to favorable project timing in Asia, slightly improved demand in North America and Europe, and realization of previously announced restructuring actions.
Scientific Group
| Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| March 31, |
% |
March 31, |
% |
|||||||||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
Change |
2025 |
2024 |
Change |
||||||||||||||||||
| Net sales |
$ | 18,292 | $ | 16,925 | 8.1 | % | $ | 54,462 | $ | 51,410 | 5.9 | % | ||||||||||||
| Income from operations |
3,895 | 4,896 | (20.4 | %) | 13,362 | 14,074 | (5.1 | %) | ||||||||||||||||
| Operating income margin |
21.3 | % | 28.9 | % | 24.5 | % | 27.4 | % | ||||||||||||||||
Net sales in the third quarter of fiscal year 2025 increased by $1.4 million, or 8.1%, when compared to the prior year quarter. The recent acquisition of Custom Biogenic Systems added $2.7 million, or 16.1%, in sales for the third quarter of fiscal year 2025. This increase was partially offset by an organic sales decrease of $1.4 million, or 8.0%, mostly due to lower demand from academic and research institutions impacted by National Institutes of Health (NIH) funding cuts.
Income from operations in the third quarter of fiscal year 2025 decreased $1.0 million, or 20.4%, when compared to the prior year quarter. The decrease is primarily driven by organic decline, partially offset by contributions from the acquisition.
Net sales in the nine months ended March 31, 2025 increased by $3.1 million, or 5.9%, when compared to the prior year period, reflecting a $4.3 million, or 8.3%, benefit from the recent acquisition, offset by an organic sales decrease of $1.2 million, or 2.4%, mostly due to lower demand from academic and research institutions impacted by NIH funding cuts.
Income from operations in the nine months ended March 31, 2025 decreased $0.7 million, or 5.1%, when compared to the prior year period. The decrease is primarily driven by organic decline, partially offset by contributions from the acquisition.
In the fourth quarter of fiscal year 2025, on a sequential basis, we expect slightly lower revenue and operating margin due to soft demand from academic and research institutions affected by NIH funding cuts and higher tariff costs.
Engineering Technologies Group
| Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| March 31, |
% |
March 31, |
% |
|||||||||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
Change |
2025 |
2024 |
Change |
||||||||||||||||||
| Net sales |
$ | 27,375 | $ | 20,098 | 36.2 | % | $ | 70,555 | $ | 58,205 | 21.2 | % | ||||||||||||
| Income from operations |
3,417 | 3,524 | (3.0 | %) | 11,120 | 9,946 | 11.8 | % | ||||||||||||||||
| Operating income margin |
12.5 | % | 17.5 | % | 15.8 | % | 17.1 | % | ||||||||||||||||
Net sales in the third quarter of fiscal year 2025 increased by $7.3 million, or 36.2%, when compared to the prior year quarter, reflecting a $5.3 million, or 26.3%, benefit from the recent acquisition of McStarlite. The organic sales increase of $2.0 million, or 9.9%, was driven by more favorable project timing in the space end market and sales growth from new products.
Income from operations in the third quarter of fiscal year 2025 decreased by $0.1 million, or 3.0%, when compared to the prior year quarter reflecting purchase accounting expenses incurred in connection with the recent acquisition, partially offset by higher volume and contributions from the recent acquisition.
Net sales in the nine months ended March 31, 2025 increased by $12.4 million, or 21.2%, when compared to the prior year period, reflecting a $5.3 million, or 9.1%, benefit from the recent acquisition. The organic sales increase of $7.3 million, or 12.5%, was driven by more favorable project timing in the space end market which helped to drive growth in new product development and new applications. Foreign currency negative impacts on net sales were $0.2 million, or 0.4%.
Income from operations in the nine months ended March 31, 2025 increased by $1.2 million, or 12.1%, when compared to the prior year period reflecting higher volume and contributions from the recent acquisition, partially offset by purchase accounting expenses incurred in connection with the recent acquisition.
In the fourth quarter of fiscal year 2025, on a sequential basis, we expect similar to slightly higher revenue and similar operating margin.
Specialty Solutions Group
| Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| March 31, |
% |
March 31, |
% |
|||||||||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
Change |
2025 |
2024 |
Change |
||||||||||||||||||
| Net sales |
$ | 20,245 | $ | 23,516 | (13.9 | %) | $ | 62,700 | $ | 71,352 | (12.1 | %) | ||||||||||||
| Income from operations |
3,278 | 4,668 | (29.8 | %) | 10,388 | 14,250 | (27.1 | %) | ||||||||||||||||
| Operating income margin |
16.2 | % | 19.9 | % | 16.6 | % | 20.0 | % | ||||||||||||||||
Net sales in the third quarter of fiscal year 2025 decreased by $3.3 million, or 13.9%, when compared to the prior year quarter. Organic sales for the group decreased $3.3 million, or 14.6%, as compared to the prior year quarter, reflecting softness in general market conditions in the Display Merchandising and Hydraulics businesses.
Income from operations in the third quarter of fiscal year 2025 decreased $1.4 million, or 29.8%, when compared to the prior year quarter, due to lower volume in the Display Merchandising and Hydraulics businesses.
Net sales in the nine months ended March 31, 2025 decreased by $8.7 million, or 12.1%, when compared to the prior year period. Organic sales for the group decreased $8.6 million, or 12.1%, as compared to the prior year period, reflecting softness in general market conditions in the Display Merchandising and Hydraulics businesses.
Income from operations in the nine months ended March 31, 2025 decreased $3.9 million, or 27.1%, when compared to the prior year period, due to lower volume in the Display Merchandising and Hydraulics businesses.
In the fourth quarter of fiscal year 2025, on a sequential basis, we expect moderately higher revenue and operating margin.
Corporate and Other
| Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
| March 31, |
% |
March 31, |
% |
|||||||||||||||||||||
| (In thousands, except percentages) |
2025 |
2024 |
Change |
2025 |
2024 |
Change |
||||||||||||||||||
| Income (loss) from operations: |
||||||||||||||||||||||||
| Corporate |
$ | (8,738 | ) | $ | (8,522 | ) | 2.5 | % | $ | (24,603 | ) | $ | (24,956 | ) | (1.4 | %) | ||||||||
| Acquisition related costs |
(2,152 | ) | (537 | ) | 300.7 | % | (20,392 | ) | (2,233 | ) | 813.2 | % | ||||||||||||
| Restructuring costs |
(1,976 | ) | (4,037 | ) | (51.1 | %) | (3,982 | ) | (7,303 | ) | (45.5 | %) | ||||||||||||
| Gain on sale of business |
- | - | - | 274 | (100.0 | %) | ||||||||||||||||||
| Other operating income (expense), net |
- | (110 | ) | (100.0 | %) | - | (110 | ) | (100.0 | %) | ||||||||||||||
Corporate expenses in the third quarter and first nine months of fiscal year 2025 were relatively flat when compared to the prior year periods. We recorded a charge of $0.1 million in other operating income (expense), net for settlement of an environmental remediation claim in the third quarter of fiscal year 2024.
The restructuring, gain on sale of business and acquisition related costs have been discussed above in the Company Overview.
Discontinued Operations
In pursuing our business strategy, the Company may divest certain businesses. Future divestitures may be classified as discontinued operations based on their strategic significance to the Company. Net income (loss) from discontinued operations was less than $0.1 million for the three and nine months ended March 31, 2025, respectively. Net income (loss) from discontinued operations was less than $0.5 million for the three and nine months ended March 31, 2024, respectively.
Liquidity and Capital Resources
At March 31, 2025, our total cash balance was $109.8 million, of which $88.8 million was held by foreign subsidiaries. The amount and timing of cash repatriation is dependent upon foreign exchange rates and each business unit’s operational needs including requirements to fund working capital, capital expenditure, and jurisdictional tax payments. The repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences or be subject to capital controls; however, those balances are generally available without legal restrictions to fund ordinary business operations.
Net cash provided by continuing operating activities for the nine months ended March 31, 2025, was $36.2 million compared to net cash provided by continuing operating activities of $64.6 million in the prior year. We generated $75.0 million from income statement activities and used $32.7 million of cash to fund working capital and other balance sheet increases. Cash flow used in investing activities for the nine months ended March 31, 2025 totaled $493.3 million and consisted of $477.4 million for the acquisition of businesses, net of cash acquired, $19.8 million used for capital expenditures offset by $3.5 million in life insurance proceeds and $0.4 million proceeds from sales of real estate and equipment. Cash used for financing activities for the nine months ended March 31, 2025 totaled $411.4 million and consisted primarily of borrowings of $792.3 million, repayments of $362.1 million, cash paid for dividends of $11.2 million, purchases of stock of $5.2 million, and $4.4 million in related financing fees.
During the third quarter of fiscal year 2023, the Company entered into a Third Amended & Restated Credit Agreement which renewed the existing Credit Agreement for an additional five-year period (“credit agreement”, or “facility”) with a borrowing limit of $500 million. The facility can be increased by an amount of up to $250 million, in accordance with specified conditions contained in the agreement. The facility also includes a $10 million sublimit for swing line loans and a $35 million sublimit for letters of credit.
Under the terms of the Credit Facility, we pay a variable rate of interest and a commitment fee on borrowed amounts as well as a commitment fee on unused amounts under the facility. The amount of the commitment fee depends upon both the undrawn amount remaining available under the facility and the Company’s funded debt to EBITDA (as defined in the agreement) ratio at the last day of each quarter. As our funded debt to EBITDA ratio increases, the commitment fee increases.
Funds borrowed under the facility may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio, are maintained), and other general corporate purposes.
During the second quarter of fiscal year 2025, the Company entered into a $250 million 364-day term loan with existing lenders. Also, during the period, we converted the 364-day term loan into an exercise of the accordion feature under our existing credit facilities. In connection with the conversion of the loan, the Company entered into a Second Amendment to Third Amended and Restated Credit Agreement. This amendment expanded the total available credit under the Revolving Credit Agreement from $500 million to $825 million.
As of March 31, 2025, the Company used $2.1 million against the letter of credit sub-facility and had the ability to borrow $169.1 million under the facility based on our current trailing twelve-month EBITDA. The facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants. The Company’s current financial covenants under the facility are as follows:
Interest Coverage Ratio The Company is required to maintain a ratio of Earnings Before Interest and Taxes, as Adjusted (“Adjusted EBIT per the Credit Facility”), to interest expense for the trailing twelve months of at least 2.75:1. Adjusted EBIT per the Credit Facility specifically excludes extraordinary and certain other defined items such as cash restructuring and acquisition related charges up to the lower of $20.0 million or 10% of EBITDA. The facility also allows for unlimited non-cash purchase accounting and goodwill adjustments. At March 31, 2025, the Company’s Interest Coverage Ratio was 9.42:1.
Leverage Ratio The Company’s ratio of funded debt to trailing twelve month Adjusted EBITDA per the Credit Facility, calculated as Adjusted EBIT per the Credit Facility plus depreciation and amortization, may not exceed 3.5:1. Under certain circumstances in connection with a Material Acquisition (as defined in the Facility), the Facility allows for the leverage ratio to go as high as 4.0:1 for a four-fiscal quarter period. At March 31, 2025, the Company’s leverage ratio was 2.78:1.
As of March 31, 2025, we had borrowings under our facility of $579.4 million. In order to manage our interest rate exposure on these borrowings, we are party to $25.0 million of active floating to fixed rate swaps. These swaps convert our interest payments from SOFR to a weighted average fixed rate of 0.81%. The effective rate of interest for our outstanding borrowings, including the impact of the interest rate swaps, was 5.63%.
Our primary cash requirements in addition to day-to-day operating needs include interest payments, capital expenditures, acquisitions, share repurchases, and dividends. Our primary sources of cash for these requirements are cash flows from continuing operations and borrowings under the facility. We expect fiscal year 2025 capital spending to be between $30.0 million and $35.0 million. We expect that fiscal year 2025 depreciation and amortization expense will be between $20.0 million and $22.0 million and $12.5 million and $14.5 million, respectively.
The following table sets forth our capitalization:
| (In thousands) |
March 31, 2025 |
June 30, 2024 |
||||||
| Long-term debt |
$ | 579,406 | $ | 148,876 | ||||
| Less cash and cash equivalents |
(109,810 | ) | (154,203 | ) | ||||
| Net (cash) debt |
469,596 | (5,327 | ) | |||||
| Total stockholders' equity |
686,928 | 621,503 | ||||||
| Total capitalization |
$ | 1,156,524 | $ | 616,176 | ||||
We sponsor a number of defined benefit and defined contribution retirement plans. The U.S. pension plan is frozen for substantially all participants. We have evaluated the current and long-term cash requirements of these plans, and our existing sources of liquidity are expected to be sufficient to cover required contributions under ERISA and other governing regulations.
The fair value of the Company's U.S. defined benefit pension plan assets was $144.1 million at March 31, 2025, as compared to $142.3 million at the most recent measurement date, which occurred as of June 30, 2024. The next measurement date to determine plan assets and benefit obligations will be on June 30, 2025.
The Company expects to pay $0.1 million in contributions to its defined benefit plans during the remainder of fiscal year 2025. Contributions of $6.2 million and $8.5 million were made during the nine months ended March 31, 2025 and March 31, 2024, respectively. The Company expects to make contributions during the remainder of fiscal year 2025 of $0.2 million and $0.3 million to its unfunded defined benefit plans in the U.S. and Germany, respectively. There are no required contributions to the plans in Japan or the U.K. Any subsequent plan contributions will depend on the results of future actuarial valuations.
We have an insurance program in place to fund supplemental retirement income benefits for two retired executives. Current executives and new hires are not eligible for this program. During the second quarter of fiscal year 2025, we received $3.5 million in proceeds under this program. At March 31, 2025, the underlying policies had a cash surrender value of $6.7 million and are reported net of loans of $2.7 million for which we have the legal right of offset, these amounts are reported net on our balance sheet.
Other Matters
Tariff – Several of our segments may be impacted by recent tariff announcements. While we cannot predict the impact of potential new tariffs on global trade and economic growth, our regional presence, strong customer relationships, and our disciplined approach to pricing and productivity actions position us well to manage through these challenges. We monitor the regulatory environment and continue to make adjustments whenever it is deemed necessary. Most of our supply chain is strategically located to service regional demand. We plan to continue to invest in our key strategic growth priorities while closely managing our cost structure and driving productivity and pricing actions and seeking alternate sources of supply to further reduce the impact of tariffs as appropriate.
Inflation – Certain of our expenses, such as wages and benefits, occupancy costs, freight and equipment repair and replacement, are subject to normal inflationary pressures. Inflation for medical costs can impact both our employee benefit costs as well as our reserves for workers' compensation claims. We monitor the inflationary rate and make adjustments to reserves whenever it is deemed necessary. Our ability to control worker compensation insurance medical cost inflation is dependent upon our ability to manage claims and purchase insurance coverage to limit the maximum exposure for us. Each of our segments is subject to the effects of changing raw material costs caused by the underlying commodity price movements. We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments. Wherever possible, we will implement price increases to offset the impact of changing prices. The ultimate acceptance of these price increases will be impacted by our affected divisions’ respective competitors and the timing of their price increases. In general, we do not enter into purchase contracts that extend beyond one operating cycle. While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage.
Foreign Currency Translation – Our primary functional currencies used by our non-U.S. subsidiaries are the Euro, British Pound Sterling (Pound), Japanese (Yen), Peso, Chinese (Yuan) and Indian (Rupee).
Defined Benefit Pension Plans – We record expenses related to these plans based upon various actuarial assumptions such as discount rates, mortality rates, and assumed rates of returns. The Company’s pension plan is frozen for substantially all eligible U.S. employees and participants in the plan ceased accruing future benefits.
Environmental Matters – To the best of our knowledge, we believe that we are presently in substantial compliance with all existing applicable environmental laws and regulations and do not anticipate any instances of non-compliance that will have a material effect on our future capital expenditures, earnings or competitive position.
Seasonality – We are a diversified business with generally low levels of seasonality.
Employee Relations – The Company has labor agreements with several union locals in the United States and several European employees belong to European trade unions.
Critical Accounting Policies
The condensed consolidated financial statements include the accounts of Standex International Corporation and all of its subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying condensed consolidated financial statements. Although we believe that materially different amounts would not be reported due to the accounting policies adopted, the application of certain accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates. Our Annual Report on Form 10-K for the year ended June 30, 2024 lists a number of accounting policies which we believe to be the most critical.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Risk Management
We are exposed to market risks from changes in interest rates, commodity prices and changes in foreign currency exchange. To reduce these risks, we selectively use, from time to time, financial instruments and other proactive management techniques. We have internal policies and procedures that place financial instruments under the direction of the Treasurer and restrict all derivative transactions to those intended for hedging purposes only. The use of financial instruments for trading purposes (except for certain investments in connection with the non-qualified defined contribution plan) or speculation is strictly prohibited. The Company has no majority-owned subsidiaries that are excluded from the consolidated financial statements. Further, we have no interests in or relationships with any special purpose entities.
Exchange Rate Risk
We are exposed to both transactional risk and translation risk associated with exchange rates. The transactional risk is mitigated, in large part, by natural hedges developed with locally denominated debt service on intercompany accounts. We also mitigate certain of our foreign currency exchange rate risks by entering into forward foreign currency contracts from time to time. The contracts are used as a hedge against anticipated foreign cash flows, such as loan payments, customer remittances, and materials purchases, and are not used for trading or speculative purposes. The fair values of the forward foreign currency exchange contracts are sensitive to changes in foreign currency exchange rates, as an adverse change in foreign currency exchange rates from market rates would decrease the fair value of the contracts. However, any such losses or gains would generally be offset by corresponding gains and losses, respectively, on the related hedged asset or liability. At March 31, 2025 the fair value, in the aggregate, of the Company’s open foreign exchange contracts was an asset of $0.2 million.
Our primary translation risk is with the Euro, British Pound Sterling, Peso, Japanese Yen and Chinese Yuan. A hypothetical 10% appreciation or depreciation of the value of any these foreign currencies to the U.S. Dollar at March 31, 2025, would not result in a material change in our operations, financial position, or cash flows. We hedge our most significant foreign currency translation risks primarily through cross currency swaps and other instruments, as appropriate.
Interest Rate Risk
The Company’s effective interest rate on borrowings was 5.63% at March 31, 2025. Our interest rate exposure is limited primarily to interest rate changes on our variable rate borrowings and is partially mitigated by our use of interest rate swap agreements to modify our exposure to interest rate movements. At March 31, 2025, we have $25.0 million of active floating to fixed rate swaps with terms through fiscal year 2025. These swaps convert our interest payments from SOFR to a weighted average rate of 0.81% on the portion of debt. At March 31, 2025, the fair value, in the aggregate, of the Company’s interest rate swaps was assets of $0.1 million. A 25-basis point increase in interest rates would increase our annual interest expense by approximately $1.5 million.
Concentration of Credit Risk
We have a diversified customer base. As such, the risk associated with concentration of credit risk is inherently minimized. As of March 31, 2025, no one customer accounted for more than 5% of our consolidated outstanding receivables or of our sales.
Commodity Prices
The Company is exposed to fluctuating market prices for all commodities used in its manufacturing processes. Each of our segments is subject to the effects of changing raw material costs caused by the underlying commodity price movements. In general, we do not enter into purchase contracts that extend beyond one operating cycle. While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage.
The Engineering Technologies, Specialty Solutions, and Electronics segments are all sensitive to price increases for steel and aluminum products, other metal commodities such as rhodium and copper, and petroleum-based products. We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments. Wherever possible, we will implement price increases to offset the impact of changing prices. The ultimate acceptance of these price increases, if implemented, will be impacted by our affected divisions’ respective competitors and the timing of their price increases.
ITEM 4. CONTROLS AND PROCEDURES
At the end of the period covered by this Report, the management of the Company, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2025 in ensuring that the information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's ("SEC") rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
There was no change in the Company's internal control over financial reporting during the quarterly period ended March 31, 2025 that has materially affected or is reasonably likely to materially affect the Company's internal control over financial reporting.
PART II. OTHER INFORMATION
Unregistered Sales of Equity Securities and Use of Proceeds
| (c) |
The following table provides information about purchases by the Company of equity securities that are registered by the Company pursuant to Section 12 of the Exchange Act: |
| Issuer Purchases of Equity Securities(1) |
| Quarter Ended March 31, 2025 |
| Period |
(a) Total number of shares (or units) purchased |
(b) Average price paid per share (or unit) |
(c) Total number of shares (or units) purchased as part of publicly announced plans or programs |
(d) Maximum number (or appropriate dollar value) of shares (or units) that may yet be purchased under the plans or programs |
||||||||||||
| January 1, 2025 - January 31, 2025 |
- | $ | - | - | $ | 28,135 | ||||||||||
| February 1, 2025 - February 28, 2025 |
- | - | - | 28,135 | ||||||||||||
| March 1, 2025 - March 31, 2025 |
- | - | - | 28,135 | ||||||||||||
| Total |
- | - | - | $ | 28,135 | |||||||||||
| (1) | The Company has a Stock Buyback Program (the “Program”) which was originally announced on January 30, 1985 and most recently amended on April 28, 2022. Under the Program, the Company is authorized to repurchase up to an aggregate of $200 million of its shares. Under the program, purchases may be made from time to time on the open market, including through 10b5-1 trading plans, or through privately negotiated transactions, block transactions, or other techniques in accordance with prevailing market conditions and the requirements of the Securities and Exchange Commission. The Board’s authorization is open-ended and does not establish a timeframe for the purchases. The Company is not obligated to acquire a particular number of shares, and the program may be discontinued at any time at the Company’s discretion. |
Except as set forth below, of our directors or executive officers adopted or terminated a Rule 10b5-1 trading arrangement or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended March 31, 2025.
| (a) |
Exhibits |
ALL OTHER ITEMS ARE INAPPLICABLE
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
STANDEX INTERNATIONAL CORPORATION |
|
|
|
|
| Date: |
May 2, 2025 | /s/ ADEMIR SARCEVIC |
|
|
|
Ademir Sarcevic |
|
|
|
Vice President/Chief Financial Officer |
|
|
|
(Principal Financial & Accounting Officer) |
|
|
|
|
| Date: |
May 2, 2025 | /s/ AMY GAGNON |
|
|
|
Amy Gagnon |
| Vice President/Chief Accounting Officer | ||